focus -WSS

focus

author：Wikipedia 2025-09-30 23:19:51 - browse：32

U.S. legislation that would sever ties with Chinese drugmakers would jeopardize the drug supply for millions of American patients if it’s passed, the biotechnology industry’s main trade group has told Congress.

Congress is considering legislation, called the BIOSECURE Act, that would make it difficult for Chinese contract development and manufacturing organizations to do business with biotechnology companies that work with the U.S. federal government. Biotechs hire Chinese CDMOs, as they’re often called, for services that include product manufacturing, development, formulation, packaging, and distribution.

The BIOSECURE Act would stop the federal government from contracting with, or providing grants to, companies that do business with so-called Chinese “companies of concern.” The impact of the legislation would depend in large part on who is in the White House. The White House’s Office of Management and Budget would determine which companies are blacklisted, but a handful of specific companies would automatically go on that list, including the biotech giant WuXi AppTec.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Phenylephrine and the overlooked value of the placebo effect

explore

WSS

Winning ticket for $1 billion Powerball jackpot sold in California

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

3 questions for the future of Biden's cancer moonshot

DeSantis talks Trump, trans issues and 'what wokeness is'

Study identifies new proteins linked to dementia risk 25 years later

knowledge

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

New air purifier tech could be key to improving indoor air quality

Ending racial health disparities hinges on penalties, political will

Supreme Court strikes down use of affirmative action

Why Congress must ban federal programs from using QALYs

Sports medicine is finally prioritizing gender equality

Colorectal cancer study finds potential in overlooked immune cell

The cancer drug shortage isn’t new — and neither are the solutions

Awakening the world to the whoosh: A patient's crusade

Drug repurposing or repositioning? The language matters

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

hotspot

Liquid biopsy for lung cancer is launched by Delfi

Why Charlie Gard's case is so disturbing to Americans

FDA authorizes Novavax’s updated Covid

Judge rejects Trump's request to move Stormy Daniels hush

A virus, fished out of a lake, may have saved a man’s life

Why age limits for politicians are a terrible idea

explore

focus

hotspot

focus